Anti-dementia drugs and hippocampal-dependent memory in rodents
- PMID: 17762506
- PMCID: PMC2666934
- DOI: 10.1097/FBP.0b013e3282da278d
Anti-dementia drugs and hippocampal-dependent memory in rodents
Abstract
Abnormalities in hippocampal structure and function are characteristics of early Alzheimer's disease (AD). Behavioral tests measuring hippocampal-dependent memory in rodents are often used to evaluate novel treatments for AD and other dementias. In this study, we review the effects of drugs marketed for the treatment of AD, such as the acetylcholinesterase inhibitors, donepezil, rivastigmine, galantamine and the N-methyl-D-aspartic acid antagonist, memantine, in rodent models of memory impairment. We also briefly describe the effects of novel treatments for cognitive impairment in rodent models of memory impairment, and discuss issues concerning the selection of the animal model and behavioral tests. Suggestions for future research are offered.
Similar articles
-
Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors enhance procognitive effects of conventional anti-Alzheimer drugs in scopolamine-treated rats.Behav Brain Res. 2020 May 15;385:112547. doi: 10.1016/j.bbr.2020.112547. Epub 2020 Feb 19. Behav Brain Res. 2020. PMID: 32087183
-
Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine.Eur J Pharmacol. 2013 Mar 5;703(1-3):53-61. doi: 10.1016/j.ejphar.2012.12.023. Epub 2012 Dec 28. Eur J Pharmacol. 2013. PMID: 23276665
-
A molecular approach in drug development for Alzheimer's disease.Biomed Pharmacother. 2018 Oct;106:553-565. doi: 10.1016/j.biopha.2018.06.147. Epub 2018 Jul 11. Biomed Pharmacother. 2018. PMID: 29990843 Review.
-
Differential effects of current specific treatments on behavioral and psychological symptoms in patients with Alzheimer's disease: a 12-month, randomized, open-label trial.J Alzheimers Dis. 2014;39(3):477-85. doi: 10.3233/JAD-131190. J Alzheimers Dis. 2014. PMID: 24164733 Clinical Trial.
-
Pharmacodynamic, pharmacokinetic and pharmacogenetic aspects of drugs used in the treatment of Alzheimer's disease.Clin Pharmacokinet. 2013 Apr;52(4):225-41. doi: 10.1007/s40262-013-0038-9. Clin Pharmacokinet. 2013. PMID: 23408070 Review.
Cited by
-
Neuroprotective effect of noncompetitive NMDA receptor antagonists IEM-1957 and memantine in experimental focal cerebral ischemia.Dokl Biol Sci. 2012 Mar-Apr;443:78-80. doi: 10.1134/S0012496612020184. Epub 2012 May 5. Dokl Biol Sci. 2012. PMID: 22562673 No abstract available.
-
Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment.Proc Natl Acad Sci U S A. 2014 Sep 9;111(36):E3825-30. doi: 10.1073/pnas.1410315111. Epub 2014 Aug 25. Proc Natl Acad Sci U S A. 2014. PMID: 25157130 Free PMC article.
-
A Chronic Longitudinal Characterization of Neurobehavioral and Neuropathological Cognitive Impairment in a Mouse Model of Gulf War Agent Exposure.Front Integr Neurosci. 2016 Jan 12;9:71. doi: 10.3389/fnint.2015.00071. eCollection 2015. Front Integr Neurosci. 2016. PMID: 26793076 Free PMC article.
-
Amyloid beta peptide-degrading microbial enzymes and its implication in drug design.3 Biotech. 2020 Jun;10(6):247. doi: 10.1007/s13205-020-02240-2. Epub 2020 May 11. 3 Biotech. 2020. PMID: 32411571 Free PMC article. Review.
-
Molecular basis of pharmacotherapies for cognition in Down syndrome.Trends Pharmacol Sci. 2010 Feb;31(2):66-73. doi: 10.1016/j.tips.2009.10.010. Epub 2009 Dec 4. Trends Pharmacol Sci. 2010. PMID: 19963286 Free PMC article. Review.
References
-
- Abe Y, Aoyaqui A, Hara T, Abe K, Yamazaki R, Kumagae Y, et al. Pharmacological characterization of RS-1259, an orally active dual inhibitor of acetylcholinesterase and serotonin transporter, in rodents: possible treatment of Alzheimer's disease. J Pharmacol Sci. 2003;93:95–105. - PubMed
-
- Areosa SA, Sherriff F, McShane R. Memantine for dementia. Cochrane Database Syst Rev. 2005;3:CD003154. - PubMed
-
- Aggleton JP, Hunt PR, Rawlins JNP. The effects of hippocampal lesions upon spatial and non-spatial tests of working memory. Behav Brain Res. 1986;19:133–146. - PubMed
-
- Alzheimer A. On a peculiar disease of the cerebral cortex. Zr Psychiatrie. 1907;64:146.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical